Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04484012 |
|---|---|
| Brief Title: | Modified Immune Cells (CD19 CAR T Cells) and Acalabrutinib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma |
| First Submitted : | July 7, 2020 |
| First Submitted that Met QC Criteria : | July 21, 2020 |
| First Posted : | July 23, 2020 |
| Last Update Submitted that Met QC Criteria : | June 16, 2022 |
| Last Update Posted : | June 21, 2022 |